Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
Mutations01:35

Mutations

42.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
42.6K
Mutations01:39

Mutations

94.2K
Overview
94.2K
Skin Cancer01:30

Skin Cancer

5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Biological Effects of Radiation02:59

Biological Effects of Radiation

17.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiation Oncology-Biology Integration Network: Bridging the Gap between Biological Research and Clinical Practice.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Integrated MRI simulation for intramedullary spinal cord arteriovenous malformation radiosurgery: illustrative case.

Journal of neurosurgery. Case lessons·2025
Same author

Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy.

Nature communications·2025
Same author

Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.

JAMA network open·2023
Same author

Mutational Status and Clinical Outcomes Following Systemic Therapy with or without Focal Radiation for Resected Melanoma Brain Metastases.

World neurosurgery·2022
Same author

Considerations for carcinogenesis countermeasure development using mouse models.

Life sciences in space research·2022

Related Experiment Video

Updated: Jan 8, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.2K

Genetic and Carcinogenic Risks of Radiotherapy for Nonmalignant Diseases.

Jean L Nakamura1

  • 1Department of Radiation Oncology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA..

Seminars in Radiation Oncology
|December 14, 2025
PubMed
Summary

Low-dose radiotherapy for nonmalignant conditions poses a low risk of secondary cancers, particularly in older patients. Factors like cumulative dosage and genetic predisposition can increase this risk.

More Related Videos

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

9.7K
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.1K

Related Experiment Videos

Last Updated: Jan 8, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.2K
Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

9.7K
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.1K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Radiotherapy is a recognized treatment for various nonmalignant diseases.
  • The use of low-dose radiotherapy for benign conditions is expanding.
  • Assessing the risks versus benefits of radiotherapy for nonmalignant conditions is crucial.

Purpose of the Study:

  • To evaluate the risk of secondary malignancies following radiotherapy for nonmalignant conditions.
  • To identify factors influencing the risk of radiation-induced cancers in patients treated for benign diseases.

Main Methods:

  • Review of existing literature and clinical data on radiotherapy for nonmalignant diseases.
  • Analysis of radiation doses typically used in nonmalignant treatments.
  • Consideration of patient demographics, particularly age and genetic factors.

Main Results:

  • Radiotherapy for nonmalignant diseases generally uses lower doses than those linked to significant cancer risks.
  • The patient population for these treatments is often older, a demographic with generally lower susceptibility to radiation-induced cancers compared to children and young adults.
  • The estimated risk of radiation-induced carcinogenesis is low for most patients receiving radiotherapy for benign conditions.

Conclusions:

  • Low-dose radiotherapy for nonmalignant conditions is associated with a low risk of secondary malignancies.
  • Increased risk factors include repeated treatments to the same area, younger patient age, and known genetic predispositions to cancer.
  • Careful patient selection and treatment planning are essential to minimize potential risks.